![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, March 03, 2022 10:00:52 PM
Can B Corp. Executes Joint Venture with PrimeX Making its CBD Products Available in Brazil
Thu, March 3, 2022, 6:00 AM
In this article:
CANBD
+13.73%
Enabling Access to the 4th Largest Pharmaceutical Market in the World and its 210 Million Consumers
HICKSVILLE, NY / ACCESSWIRE / March 3, 2022 / Can B Corp. (OTCQB:CANBD) ("Can B'' or the "Company"), a health and wellness company specializing in developing, producing, and selling hemp-derived cannabinoid products, is pleased to announce its formation of a joint venture with PrimeX, a marketing, sales, and distribution company, for its CBD products in Brazil.
PrimeX has a contract with Biocase Brasil to produce CBD products for the Brazilian market.
Biocase is a company focused on: local distribution, an intensive education program for doctors (MDs), production of oils, capsules, and creams through local facilities, and the development of a biotech laboratory for cannabis testing and extraction.
Biocase Brasil has a strong network of doctors in Brazil and provides education, research, products development, and tests for the Brazilian market. Brazil relies on medical clinical trials to test CBD products for new categories, such as beauty, veterinary use, and food, before regulation permits the distribution to pharmacies and online sales. BiocaseBrasil patients' also have access to prescriptions and Anvisa licenses!
PrimeX services 120,000 retailers in Brazil, which includes markets, pharmacies, and bodegas, a country that recently approved the sale of CBD products in pharmacies. The joint venture will utilize PrimeX's existing distribution relationships in Brazil.
The largest country in South America, Brazil is the fourth biggest pharmaceutical market in the world. The Brazilian National Health System is one of the largest public health systems in the world. In 2019, Brazil had 114,352 community pharmacies (76.8% privately owned), which represent the first point of access to healthcare in Brazil due to their wide distribution.
Medical cannabis and CBD are expected to surge in Brazil with the passage of new legislation, with estimates that the sector could reach $4.7 billion in sales in the next three years. Up until recently, CBD in Brazil was permitted only for medical use with authorization from the National Sanitary Surveillance Agency. Regulations are in place for medical cannabis and hemp opening up a market of 210 million consumers.
There are only a few companies in Brazil - CBD Vida being one- selling CBD-based pharmaceuticals through prescription and medical reports, Only a handful of importers have established distribution in Brazil, including GW Pharmaceuticals, Biocase Brazil, which sells its Sativex CBD-based medicine in pharmacies, and Biocase sells Allandiol Full and Broad.
Mario Lacourt, PrimeX's Chief Executive Officer, stated, "We are very excited to roll out Can B's CBD products in Brazil. After careful consideration, Biocase Brasil chose Can B for its high standards of manufacturing and processing and quality products. The CBD category in Brazil is ever-expanding to new categories and we are very well-positioned to distribute Can B's products to the majority of pharmacies, markets, and bodegas in Brazil."
Marco Alfonsi, Can B's Chief Executive Officer, stated, "This is a significant expansion milestone for our company as Brazil is the fourth biggest pharmaceutical market in the world and we now have access to this huge market via PrimeX. The CBD opportunity in Brazil is emerging with recently passed legislation that is opening up the market to its 210 million people. We look forward to working closely with PrimeX and utilizing its existing relationships with pharmacies in Brazil."
About PrimeX
PrimeX distributes and markets hemp, CBD, D8 smokable, and consumable products in the USA and internationally. PrimeX works with clients to fulfill all their hemp-derived products globally by partnering with companies alike (for example, Dicina 120,000+ points of sale). With access to raw material, pre-roll smokes rolled at 1600/minute to pharmaceutical grade products, PrimeX works to provide top-shelf consumer access.
For additional information, please visit:
https://sateevajoints.com
https://www.biocasebrasil.com
About Can B Corp.
Can B Corp. (OTCQB:CANB) is a health & wellness company providing the highest quality hemp-derived cannabinoid products, including under its own brands of Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil, and Duramed. Can B utilizes multi-channel distribution to reach consumers, including medical facilities, doctor offices, retailers, online and direct. Can B Corp. operates R&D and production facilities in Lacey, WA, and Florida. To learn more about Can B Corp. and our comprehensive line of high-quality products, please visit: Canbiola.com and www.CanBCorp.com, follow Can B Corp on Instagram and Facebook, or visit one of the 1,000+ retail outlets that carry Can B Corp. products.
For more information about Can B Corp., please visit: CanBCorp.com
Twitter @CanBCorp
Instagram @canbcorp
Facebook @ Can B Corp
YouTube
Forward-Looking Statements
Forward-looking statements and risks and uncertainties discussed in this release contain forward-looking statements. The words "anticipate," "believe," "estimate," "may," "intend," "expect," and similar expressions identify such forward-looking statements. Expected, actual results, performance, or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements contained herein. Forward-looking statements are subject to a number of risks and uncertainties, including but not limited to, risks and uncertainties associated with, among other things, the impact of economic, competitive, and other factors affecting our operations, markets, products, and performance. The matters discussed herein should not be construed in any way, shape, or manner of our future financial condition or stock price. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of the latest information, future events, or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.
Investors and Media:
IR@canbiola.com
(917) 658-7878
•Much success can be attributed to inactivity. Most investors cannot resist the temptation to constantly buy and sell.
•Only buy something that you’d be perfectly happy to hold if the market shut down for 10 years.
Warren Buffett
Recent CANB News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 08:58:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/31/2024 05:29:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/20/2024 09:08:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 08:54:44 PM
- Can B Corp. Secures Ownership and Control of Two Cannabis Patents Valued at $122 Million and Potentially in Excess of $750 Million • InvestorsHub NewsWire • 03/11/2024 12:34:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 10:15:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 10:02:41 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:38:08 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 04:52:26 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/08/2024 06:08:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 12:52:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 03:36:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 10:15:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:18:08 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/13/2023 02:44:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 06:24:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2023 08:57:21 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 09:12:43 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:41:28 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM